DFX Intelligence

RIA Intelligence

The names on this page are hidden. Create a free account to reveal 5 records a month, or get RIA and Wealth Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Private fund

B•• H•••••• F•••• L•• • H••• S•••••

Other Private Fundadvised byB•••••• G••••• A•••••••• L••independent RIA805-8204040029IAPD
Gross asset value
$0
as of Jun 30, 2026; not a fund size
Peak GAV
$10.0M
highest filing
Owners
20
beneficial owners reported
Minimum investment
n/a
as reported
Adviser and related own
0%
of the fund
Owned by funds
0%
fund-of-funds interests
Non-US owners
0%
Reported
27 filings
Mar 24, 2015 to Jun 30, 2026
Reporting history
one row per Form ADV filing
Gross asset value$3.9M as of Jul 2, 2024
Mar 24, 2015$10.0M then
Owners20 as of Jul 2, 2024
Mar 24, 201517 then
Structure
Exclusion
3(c)(7), qualified purchasersreported
Master or feeder
standalonereported
Fund of funds
yesreported
Organized in
Delaware, United Statesreported
Clients solicited
yes, 6% of the adviser's clients investedreported
Form D file number
021-219136reportedthe join to the Form D offering
Type as written
PHARMACEUTICAL ROYALTIESreported
Custodians
Schedule D 7.B.(1).A.25, latest filing
  • Cambridge Trust Company
    Cambridge, Massachusetts
Across DFX
shared identifiers only
This fund id is not on the venture or private equity graphs.
Provenance
Source
Form ADV Schedule D 7.B.(1), every filing 2011 to 2024reportedadviserinfo.sec.gov
Status
on the adviser's latest filing in the extractderived
Share
0.0%reportedadviser and related persons